Health Condition 1: N926- Irregular menstruation, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 Patient willing to give voluntary informed consent 2 Female patient of age group between 16-40 years (both married and unmarried) ASRM / ESHRM (Rotterdam) criteria- Affected patient must follow two out of three criteria (1) Oligo and/or anovulation (2) Hyperandrogenism (clinical / biochemical) (3) Polycystic ovaries (confirmed or USG) 3 BMI more than 24.9
Exclusion criteria
Exclusion criteria: 1 Patient who is not willing to give voluntary informed consent 2 Women of age from 16years to 40 years 3 BMI less than 24.9 4 Patient with chronic systemic illness (cardiac failure cirrhosis of liver hypertension diabetes mellitus tuberculosis chronic renal disease) 5 Patient with reproductive system abnormalities (excluded clinically and radiologically hydrosalpinx endometrosis adenomyosis carcinoma of reproductive organ) 6 Long term medication 7 Any type of malignancy 8 Patient with positive STDs HIV Hepatitis B antigen (HBsAg) 9 Patient suffering from adrenal hyperplasia severe insulin resistant androgen secreting neoplasm thyroid abnormalities cushing syndrome
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To reduce or resolve the number and size of cystTimepoint: FOLLOW UP FOR SUBJECTIVE SYMPTOMS AFTER EVERY 1 MONTH AND FOR OBJECTIVE SYMPTOMS AFTER 3 MONTHS | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in other associated clinical feature related to Polycystic ovarian syndrome (PCOS)Timepoint: FOLLOW UP FOR SUBJECTIVE SYMPTOMS AFTER EVERY 1 MONTH AND FOR OBJECTIVE SYMPTOMS AFTER 3 MONTHS | — |
Countries
India
Contacts
Institue for Ayurved Studies and Research Umri Road Sector 08